Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness Broadens Glucose Monitoring Portfolio Via LXN Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Inverness Medical Technology's acquisition of privately held LXN Corp., and with it the InCharge GlucoProtein home test, expands the firm's presence in the Type 2 diabetes market.

You may also be interested in...



Given Imaging Goes Public, TheraSense Up Next Despite Market Uncertainties

TheraSense and Given Imaging are moving forward with planned initial public offerings despite a volatile economic environment in the wake of the Sept. 11 terrorist attacks..

Given Imaging Goes Public, TheraSense Up Next Despite Market Uncertainties

TheraSense and Given Imaging are moving forward with planned initial public offerings despite a volatile economic environment in the wake of the Sept. 11 terrorist attacks..

LXN Hopes To Stay In Charge of Diabetes Control Market With $57.5 Mil. IPO

LXN's agreement to supply Bristol-Myers Squibb with the company's In Charge for expanded indications of the diabetes drug Glucovance will translate into greater sales of the home glucose monitoring system, according to an Oct. 16 initial public offering prospectus filed with the Securities and Exchange Commission.

Related Content

UsernamePublicRestriction

Register

MT014531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel